Agilent Technologies Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 07:05PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

[Good noon,] everybody. Luke Sergott. I cover the Life Science Tools and Diagnostics here at Barclays. I think I got that part right. Today, I have Bob McMahon with me, CFO of Agilent. It's great to have you here.

Questions and Answers:

Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

To start off key questions on all the investment right now is trying to -- there's been a lot of confusion on how the [growth] was trended particularly in LSAG throughout the quarter. So I want to dive in there and talk about the trends that you're seeing and ultimately, how the backlog built order did not...

Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO

Yes. As well, it's great to be here and particularly coming from California where never-ending rain. It's good to see, although today (inaudible) but certainly appreciate you being -- having the opportunity to talk to (inaudible) and talk with I would
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot